Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 173
1958 213
1959 155
1960 77
1961 61
1962 37
1964 1
1965 31
1966 32
1967 64
1968 91
1969 169
1970 120
1971 120
1972 90
1973 91
1974 87
1975 73
1976 70
1977 58
1978 48
1979 66
1980 32
1981 40
1982 41
1983 49
1984 68
1985 53
1986 44
1987 37
1988 57
1989 58
1990 62
1991 85
1992 95
1993 105
1994 116
1995 285
1996 439
1997 618
1998 678
1999 691
2000 762
2001 767
2002 994
2003 973
2004 1118
2005 1196
2006 1409
2007 1720
2008 1800
2009 2118
2010 2261
2011 2365
2012 2692
2013 2656
2014 2902
2015 2929
2016 2882
2017 3081
2018 3088
2019 2102
2020 112
Text availability
Article attribute
Article type
Publication date

Search Results

40,951 results
Results by year
Filters applied: . Clear all
Page 1
Cardiovascular Protection with Anti-hyperglycemic Agents.
Deedwania P, Acharya T. Deedwania P, et al. Am J Cardiovasc Drugs. 2019 Jun;19(3):249-257. doi: 10.1007/s40256-019-00325-9. Am J Cardiovasc Drugs. 2019. PMID: 30767126 Review.
Hypoglycemic agents in the management of type 2 diabetes mellitus.
Ho J, Leung AK, Rabi D. Ho J, et al. Recent Pat Endocr Metab Immune Drug Discov. 2011 Jan;5(1):66-73. doi: 10.2174/187221411794351879. Recent Pat Endocr Metab Immune Drug Discov. 2011. PMID: 22074580 Review.
Dapagliflozin: A Review in Type 1 Diabetes.
Paik J, Blair HA. Paik J, et al. Drugs. 2019 Nov;79(17):1877-1884. doi: 10.1007/s40265-019-01213-x. Drugs. 2019. PMID: 31664708 Free PMC article. Review.
Risks Associated with SGLT2 Inhibitors: An Overview.
Singh M, Kumar A. Singh M, et al. Curr Drug Saf. 2018;13(2):84-91. doi: 10.2174/1574886313666180226103408. Curr Drug Saf. 2018. PMID: 29485006 Review.
CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle.
Schernthaner G, Wanner C, Jurišić-Eržen D, Guja C, Gumprecht J, Jarek-Martynowa IR, Karasik A, Lalić N, Mankovsky BN, Prázný M, Tankova T, Tsur A, Wascher TC, Wittmann I. Schernthaner G, et al. Diabetes Res Clin Pract. 2019 Jul;153:30-40. doi: 10.1016/j.diabres.2019.05.013. Epub 2019 May 20. Diabetes Res Clin Pract. 2019. PMID: 31121272 Free article.
Clinical use of oral hypoglycemic agents.
Hagg SA. Hagg SA. Am J Hosp Pharm. 1976 Sep;33(9):943-7. Am J Hosp Pharm. 1976. PMID: 790951 Review.
Remogliflozin Etabonate: First Global Approval.
Markham A. Markham A. Drugs. 2019 Jul;79(10):1157-1161. doi: 10.1007/s40265-019-01150-9. Drugs. 2019. PMID: 31201711 Review.
Type 2 Diabetes Therapies: A STEPS Approach.
Steinberg J, Carlson L. Steinberg J, et al. Am Fam Physician. 2019 Feb 15;99(4):237-243. Am Fam Physician. 2019. PMID: 30763055 Free article. Review.
40,951 results
Jump to page
Feedback